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Cadre : Policlinique pédiatrique à Lausanne en Suisse, pays rencontrant une 
proportion importante de tuberculose au sein de la population de migrants. 
But: Déterminer les facteurs de risque associés à un test tuberculinique positif (ou 
test de Mantoux), notamment l'influence du BCG (Bacille Calmette Guérin) et d'un 
contact avec un personne ayant une tuberculose active. Les patients concernés 
étaient des enfants examinés dans le cadre d'un contrôle de santé ou dans le cadre 
d'une étude d'entourage d'un cas déclaré de tuberculose. 
Méthode: Etude descriptive comprenant des enfants ayant eu un test tuberculinique 
(2 unités RT23) entre novembre 2002 et avril 2004. L'âge, le sexe, l'anamnèse de 
contact avec une personne ayant une tuberculose active, la vaccination par le BCG, 
le pays d'origine et le lieu de naissance (en Suisse ou hors de la Suisse) étaient 
répertoriés. 
Résultats: Parmi les 234 enfants de l'étude, 176 (75%) avaient une réaction 
tuberculinique égal à zéro et 31 (13%) avaient une réaction positive(> 10mm). Dans 
le modèle de régression linéaire, la taille de la réaction tuberculinique variait 
significativement selon l'anamnèse de contact avec une personne ayant une 
tuberculose active, l'âge, l'incidence de la tuberculose dans le pays d'origine et la 
vaccination par le BCG. Le sexe ou le lieu de naissance n'influençait pas la taille de 
la réaction. 
Dans le modèle de régression logistique incluant toutes les valeurs répertoriées, les 
paramètres significativement associés avec un Mantoux positif étaient l'âge (Odds 
Ratio = 1.21, 95% Cl 1.08 ; 1.35), l'anamnèse de contact avec une personne ayant 
une tuberculose active (OR= 7.31, 95% Cl 2.23; 24) et l'incidence de la tuberculose 
dans le pays d'origine (OR = 1.01, 95% Cl 1.00 ; 1.02). Le sexe (OR = 1.18, 95% Cl 
0.50; 2.78) et la vaccination par le BCG (OR = 2.97, 95% Cl 0.91 ; 9.72) n'étaient 
pas associés avec une réaction tuberculinique positive. 
Conclusions : L'incidence de la tuberculose dans le pays d'origine, la vaccination 
par le BCG et l'âge influencent le test de Mantoux (taille ou proportion de réaction >. 
1 Omm). Toutefois, le facteur de risque le plus important d'avoir une réaction 
tuberculinique positive est l'anamnèse de contact avec une personne ~yant une 
tuberculose active. 
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Summary 
Setting: Ambulatory paediatric clinic in Lau-
sanne, Switzerland, a country with a significant 
proportion of tuberculosis (TB) among immi-
grants. 
Aim: To assess the factors associated with pos-
itive tuberculin skin tests (TST) among children 
examined during a health check-up or during TB 
contact tracing, notably the influence of BCG vac-
cination (Bacille Calmette Guérin) and history of 
TB contact. 
Method: A descriptive study of children who 
had a TST (2 Units RT23) between November 
2002 and April 2004. Age, sex, history of TB con-
tact, BCG vaccination status, country of origin and 
birth outside Switzerland were recorded. 
Results: Of 2 34 children, 17 6 (7 5 % ) had a re-
action equal to zero and 31 (13 % ) tested positive 
(> 10 mm). In a linear regression model, the size of 
the TST varied significantly according to the his-
tory of TB contact, age, TB incidence in the coun-
Introduction 
In Switzerland, during the year 2004, 601 new 
cases of TB were declared to the Swiss Federal Of-
fice of Public Health, representing an incidence 
rate of approximately 8/100,000 inhabitants. The 
majority of TB cases were found among foreign-
born persons, including recent immigrants. 
Among those, an important proportion of cases in-
volved young adults and children. 47 (8%) patients 
were less than 20 years old and 11 (2%) less than 
4years old (1). To date, 132,000 recentlegal immi-
grants are living in Switzerland (2). Approximately 
70,000-180,000 estimated illegal immigrants from 
moderate to high TB incidence countries can be 
added to this number (3]. Consequently; our coun-
try is directly involved in TB control, especially in 
the paediatric age group. 
Among children infected with Mycobacterium 
tubercuwsis, 95% will not present active infection 
try of origin and BCG vaccination status but not 
according to sex or birth in or outside Switzerland. 
In a logistic regression model including all the 
recorded variables, age (Odds Ratio = 1.21, 95% 
CI 1.08; 1.35), a historyofTB contact (OR= 7.31, 
95% CI 2.23; 24) and the incidence of TB in the 
country oforigin (OR= 1.01, 95% CI 1.00; 1.02) 
were significantly associated with a positive TST 
but sex (OR= 1.18, 95% CI 0.50; 2.78) and BCG 
vaccination status (OR= 2.97, 95% CI 0.91; 9.72) 
were not associated. 
Conclusions: TB incidence in the country of ori-
gin, BCG vaccination and age influence the TST 
reaction (size or proportion of TST ::::10 mm). 
However the most obvious risk factor for a posi-
tive TST is a history of contact with TB. 
Key words: tubercuwsis; chi/.dren; immigrants; 
Switzerland; tuberculin skin test 
(i.e. pulmonary or miliary disease, meningitis or 
osteomyelitis) but a latent disease called Latent Tu-
berculosis Infection (LTBI). 5-10% of these chil-
dren in apparent good health will go on to develop 
active disease, half of them in the following two 
years. The identification of these patients with 
LTBI, representing a reservoir of M. tubercuwsis, 
Glossary 
TB Tuberculosis 
LTBI Latent Tuberculosis Infection 
TST Tuberculin Skin Test 
BCG Bacillus Calmette-Guérin 
HEL Hôpital de !'Enfance de Lausanne, 
University Children's Hospital 
WHO World Health Organization 
Risk factors for positive tuberculin skin tests among migrant and resident children 
has been regarded as an essential part of the global 
control programme in countries with a low TB 
incidence [4] and for almost 100 years has been 
largely dependent on the Tuberculin Skin Test 
(fST). Appropriate interpretation of TST is 
therefore crucial. The major factors, described as 
influencing the TST, are M. wberculosis infection 
(acquired by a contact with a person suffering from 
active TB), BCG (Bacille Calmette Guérin) immu-
nization and cross reaction with other non-tuber-
culous environmental mycobacteria. 
A recent case-control study was performed in 
several primary care clinics among Hispanie chil-
dren in New York City. Contact with an adult with 
a positive TST (2::10 mm) or with active TB was the 
most significant predictor of a positive TST in 
children. Previous BCG vaccination itself was not 
a risk factor [5]. However, BCG immunization has 
been described as a confounding factor in many ar-
ticles and is considered to represent a constant 
problem in the interpretation of a TST reaction. 
The proportion of positive TST after BCG vacci-
nation has been reported to vary from 0% [ 6] to 
90% [7]. 
Participants and methods 
Study design 
A descriptive study of all children who received a 
TST at the outpatient clinic of the Hôpital de !'Enfance 
de Lausanne (HEL) was conducted between November 
2002 and April 2004. During the study period, a complete 
dataset was obtained for each child who had a TST. 
Study site 
The outpatient clinic of the Hôpital de !'Enfance de 
Lausanne (HEL). In 2001, the outpatient clinic of the 
HEL received 35'000 patients ofwhom 70% were immi-
grant children. Approximately 200 TST per year were 
performed among them. 
Indications to TST 
In accordance with the national guidelines of the 
Swiss Lung Association, TST is currently only used for 
detection of LTBI in immigrant children, in children of 
foreign workers (at least one foreign-born parent) and for 
TB contact tracing [13]. 
Exclusion criteria 
Immunodeficientpatients and patients known to have 
an exaggerated TST reaction were excluded. 
TST methodology 
Patients underwent an intradermal injection of2 TU 
ofRT23 Copenhagen (bioequivalent to 5 TU of PPD-S). 
The transverse diameter of the induration (and not the 
erythema) was measured 48-72 hours later by the clinic 
physician. Reactions were considered to be positive with 
an induration of:?:l 0 mm [13]. 
Data collection 
During the visit, the physician completed a standard-
ised questionnaire on demographic characteristics, for-
eign birth or origin, previous TST, BCGvaccination and 
contact with a person suffering from TB. 
704 
Cross reaction with non-tuberculous my-
cobacteria depends on the environment and con-
sequently differs from one population to another 
[8-11]. 
Most of these studies were carried out among 
schoolchildren and young adults living in coun-
tries with a low TB incidence. However, since the 
positive predictive value of the TST depends on 
the prevalence pre-test, it is affected by the coun-
try of origin. When screening a Canadian-born 
population, it may range from 17 % to 78 % among 
recent immigrants from TB endemic regions [12]. 
The number of inn,nigrant children is increas-
ing in all European countries but, to our knowl-
edge, there are no systematic european studies of 
the risk factors for positive TST reaction in chil-
dren. The aim of our study was to evaluate the ef-
fect of age, sex, foreign origin, birth outside of 
Switzerland, contact with an adult suffering from 
TB and BCG immunization status on TST reac-
tion in such a population. The determination of 
these parameters could help clinical staff to inter-
pret the TST reaction and guide them through the 
treatment decision process. 
The history of contact with a TB case was reported 
as "yes", "no" or "unknown'', if the patient did not remem-
ber. For our analysis, we considered only two categories: 
"known" and "not known" ("no" and "unknown"). The 
notification of the BCG status was based on the presence 
of a BCG scar or according to the vaccination booklet 
[14-16]. It was reported as ''yes", "no" or "several" if the 
child had more than one documented BCG vaccination. 
The children were distributed into five age categories 
(0-2, 3-5, 6-8, 9-11, 12-16years). We classified the coun-
tries of origin into nine categories according to the classi-
fication of the Global TB Control WHO Report 2004. 
For each country of origin, the TB incidence rate (case no-
tification rates) was extracted from the above report [17]. 
Follow-up of the patients 
Following the guidelines of the Swiss Lung Associa-
tion, children with a TST :?:10 mm underwent a chest X-
ray. Gastrie fluid was obtained on three separate momings 
for culture and PCR, if the standard chest X-ray was ab-
normal. The detailed history of a TB contact was further 
investigated. Children with a TST :=::10 mm and normal 
chest x-rays were considered to have LTBI and were 
treated with isoniazid 10 mg/kg/dayfor nine months, with 
monthly follow-up. Equivocal cases were discussed with a 
specialist for respira tory medicine. 
Data analysis 
Data were entered and managed in a FileMaker Pro 
4.1 database and analysed using Stata 8.0. Firstly, we per-
formed a descriptive analysis of the demographic charac-
teristics. The results for quantitative variables are given as 
mean (standard deviation) unless stated otherwise. Sec-
ondly, we considered two different analyses to identify in-
dependent factors associated with TST size and positivity. 
The first mode! was a multivariate linear regression 
with TST size as a linear response and the second was a 
multivariate logistic regression with TST as a binary re-
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sponse variable: TST size inferior, superior, or equal to 
10 mm. Both these models were useful. The first one was 
more powerful and the second one was more convenient, 
as this 10 mm eut-off is commonly used by physicians to 
establish a diagnosis. The potentially confounding factors 
were set as predictor variables in both models: age (in 
years), sex, history of contact (known versus no or un-
known), BCG vaccination, TB incidence rate in country 
of origin and native country (Switzerland versus other) and 
an interaction term between BCG and history of contact. 
BCG vaccination was a three categorical variable: 
one, several or no vaccination. Since there were few chil-
dren with several vaccinations, we did a sensitivity analy-
Results 
Between November 2002 and April 2004, we 
recorded 241 TST in 241 children. We excluded 
seven children because we were unable to deter-
mine their BCG vaccination status and therefore 
234 children remained in tqe sample. There were 
198 (85%) immigrant children (foreign born). 
Among the children born in Switzerland, 2 8 (12 % ) 
were children of foreign-born parents, 6 (2 % ) 
were included in a contact tracing and 2 (1 % ) had 
recurrentsymptoms. No children presented exclu-
sion criteria. 
Demographic charàcteristics 
of the study population. 
Results are given as means (standard deviation) 
unless stated otherwise. 
The study population was composed of 113 
(48%)malesand 121 (52%)females.Themeanage 
of the children was 8 (4) years. Males were 9 (4) 
years old and females 7 (4) years old. 
157 (67%) children had been vaccinated with 
BCG, of which 9 ( 4 % ) had been vaccinated several 
times. The children with several BCG were 12 (3) 
years old, which is older than the children who had 
been vaccinated only once or not at all, respectively 
8 (4) and 8 (5) years old. The proportion of sub-
jects with several BCG vaccinations was greater 
among males (8 males for 1 female). 
21 (9%) children had a history of contact. 
Although most of the children came from Es-
tablished Market Economy countries and Latin 
America, there were children from all main regions 
in the world. 
ChestX-raywere performed in 40 patients (in-
dications for children with a TST <10 mm were 
symptoms suggesting another pulmonary disease). 
One gastric fluid culture was performed and was 
negative. 
Descriptive analysis of the factors 
associated with TST 
Results of sex distribution, age, BCG vaccina-
tion status, history of contact, country of origin 
and native country for ail children are reported in 
table 1. The table also shows the size ofTST and 
sis to decide on the most appropriate coding of BCG. We 
then compared the mode! using BCG as a three categor-
ical variable with the one using BCG as a binaryvariable. 
As the second mode! was nested in the first one, we used 
a likelihood ratio test to compare these models. These sen-
sitivity analyses helped us to decide on the most appropri-
a te coding of BCG. 
Ethical consent 
The study was reviewed and approved by the local 
Ethical Committee (Comité d'éthique de la recherche 
clinique, Faculté de médecine de Lausanne). 
the proportion ofTST <10 mm and TST ~10 mm 
according to these factors. The size of the TSTwas 
inhomogeneous with 176 (75%) TST equal to 0 
mm, 28 (12%) betweenOand lOmmand 30 (13%) 
equal to or greater than 10 mm. The mean size of 
TST in the children with a TST '#. 0 was 11 (7) mm. 
Linear and logisitic regression 
analysis of risk factors. 
Table 2 and 3 present both final models. 
ln the sensitivity analysis, no differences be-
tween parameter estimates were detected using 
models with or without the 9 children with several 
BCG vaccinations, for bath linear and logistic 
models. Furthermore, the likelihood ratio test was 
not statistically significant for both models. Fi-
nally, a binary coding was chosen for BCG. 
In the linear regression model, the history of 
contact (coefficient 7.06, 95% CI 3.81; 10.3), age 
(0.33, 95% CI0.16; 0.50), incidence rate in the na-
tive country (0.025, 95% CI 0.01; 0.04) and BCG 
vaccination (1.74, 95% CI 0.02; 3.46) were inde-
pendent risk factors associated with larger TST re-
actions. We added an interaction term between 
BCG and history of contact, which was significant 
in this analysis (-5.95, 95% CI-10.7; -1.16), and 
calculated the coefficient of mean increase of the 
TST reaction with contact and vaccination (7 .06 + 
1.74-5.95 =2.85). 
In the logistic regression model, the factors 
significantly associated with a positive TST were 
history of contact (Odds Ratio = 7.31, 95% CI 
2.23; 24), age (OR= 1.21, 95% CI 1.08; 1.35) and 
incidence rate in the country of origin (OR= 1.01, 
95% CI 1.00; 1.02). BCG vaccination was not an 
independent factor (OR = 2.97, 95% CI 0.91; 
9. 72). The interaction term between BCG and his-
tory of contact was not significant. 
We added a second interaction term between 
BCG and age, which was not significant in either 
model. We compared the models with and with-
out interaction term using a likelihood ratio test. 
The nested models with the interaction term were 
not better than the other models. 
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Table 1 
Descriptive analysis 
of the study popula· 
tion. 
Table 2 
Linear regression 
analysis of risk fac· 
tors for Tuberculin 
Skin Test size. 
TST size-" (mm) 
n(%) TST size = 0 mm TST size -" nun TST size (mm) TST <10 mm TST <':10 mm 
n(%) n(%) Mean(SD) n(%) n(%) 
Ail children 234 (100) 176 (75) 58 (25) 11 (7) 27 (47) 31 (53) 
Sex 
Female 121 (52) 95 (79) 26 (21) 11 (7) 11 (42) 15 (58) 
Male 113 (48) Sl (72) 32 (28) 10 (7) 16 (50) 16 (50) 
Age groups, years 
0-2 32 (14) 23 (72) 9 (28) 5 (5) 7 (78) 2 (22) 
3-5 49 (21) 43 (88) 6 (12) 9 (3) 3 (50) 3 (50) 
6-8 61 (26) 49 (80) 12 (20) 11 (7) 5 (42) 7 (58) 
9-11 44 (19) 36 (82) 8 (18) 10 (7) 5 (63) 3 (37) 
12-16 48 (20) 25 (52) 23 (48) 14 (7) 7 (30) 16 (70) 
BCG vaccination 
No 77 (33) 62 (80) 15 (20) 14 (10) 5 (33) 10 (67) 
One 148 (63) 109 (74) 39 (26) 10 (6) 21 (54) 18 (46) 
Severa! 9 (4) 5 (56) 4 (44) 11 (4) l (25) 3 (75) 
History of contact 
No or unknown 213 (91) 163 (77) 50 (23) 10 (6) 27 (54) 23 (46) 
Known 21 (9) 13 (62) 8 (38) 18 (7) 0 8 (100) 
Country of origin (incidence rates per 1OO000: median[range])) 
Africa 27 (12) 13 (48) 14 (52) 14 (8) 5 (36) 9 (64) 
(228 [32;250]) 
Central Europe 24 (10) 19 (79) 5 (21) 8 (7) 3 (60) 2 (40) 
(40 [19;41]) 
Eastern Europe 4(2) 3 (75) l (25) 14 0 1 (100) 
(86 [82;89]) 
Eastern Mediterranean 12 (5) 9 (75) 3 (25) 19 (9) 0 3 (100) 
(27 [16;77]) 
Established Market 50 (21) 46 (92) 4 (8) 13 (8) l (25) 3 (75) 
Economy * (8 [8;44]) 
Latin America 110 (47) 81 (74) 29 (26) 9 (5) 16 (55) 13 (45) 
(46 [16;135]) 
South East Asia 5 (2) 4 (80) l (20) 4 1 (100) 0 
(101 [80;101]) 
Western Pacifie 2 (1) l (50) l (50) 7 1 (100) 0 
(78 [36;119]) 
Native country 
Switzerland 36 (15) 34 (94) 2 (6) 20 (3) 0 2 (100) 
Other 198 (85) 142 (72) 56 (28) 11 (7) 27 (48) 29 (52) 
* Australia, Austria, Belgium, Canada, Czech Rep, Denmark, Finland, France, Germany; Greece, Iceland, Ireland, Japan, Luxembourg, 
Netherlands, New Zealand, Norway, Portugal, Singapore, Spain, Sweden, Switzerland, United Kingdom, United States. 
Variable Coefficient CI95% 
Age (years) 0.33 [0.16; 0.50] 
Sex (male/female) 0.24 [-1.12; 1.61] 
Contact (yes/no or unknown) 7.06 [3.81; 10.3] 
BCG vaccination (yes/no) 1. 7 4 [0.02; 3.46] 
TB incidence rate in country of origin (per 100000) 0.025 [0.01; O.o4] 
Native country (Switzerland/other) 0.63 [-1.60; 2.85] 
BCG*contact * -5 .95 [-10.7; -1.16] 
BCG = Bacille Calmette Guérin, TB = Tuberculosis 
* Interaction term between BCG vaccination and history of contact 
Tobie 3 
Logistic regression 
analysis of risk 
factors for positive 
Tuberculin Skin Test. 
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Variable Odds mtio CI95% 
Age (years) 1.21 
Sex (male/female) 1.18 
Contact (yes/no or unknown) 7.31 
BCG vaccination (yes/no) 2.97 
TB incidence rate in country of origin (per 100000) 1.01 
Native country (Switzerlandlother) 0.92 
BCG = Bacille Calmette Guérin, TB = Tuberculosis 
Discussion 
According to the Global TB Control Program 
WHO, targeting screening ofLTBI on the high-
endemic paediatric population is essential. In-
fected children are an important source of future 
active TB and the youngest .are at higher risk of 
serious disseminated disease. In Switzerland, it is 
known that in a population of 15 year-old children, 
the foreign borns have a prevalence of positive 
TST approximately twofold higher than indige-
nous children [18]. However, to our knowledge, 
our study is the only study in Switzerland, or even 
in Europe, of the major factors associated with pos-
itive TST in children. 
The most obvious risk factor for a positive 
TST in our study was a history of TB contact. 
Large or strongly positive TST reactions are com-
monly associated with exposure to a person suffer-
ing from active TB (19]. In addition, the proxim-
ity of the contact case is a known risk factor for 
infection [20]. We also showed that coming from 
countries with a high TB incidence, such as those 
in Africa (3 2-2 50110 000), is a risk factor for a TST 
;:::10 mm. These findings emphasize the impor-
tance of inquiring about previous domicile and 
travel and of targeting surveillance on this partic-
ular child population. 
In a population of migrant children, BCG cov-
erage is commonly high (67% in our study with 
85% of migrant children) and influence of vacci-
nation on the TST reaction is a recurrent difficulty 
for the medical team. The 10 mm eut-off point for 
positive TST that we considered in our study is an 
arbitrary value1 This is the value used in the clini-
cal practice and recommended for the detection of 
paediatric TB infection and the indication for 
chemopreventive treatrnents and follow-up [13]. 
Our study was not designed or powered to look for 
different eut-off points. BCG vaccination had 
some influence on the size of the reaction but was 
not an independent risk factor for a positive TST 
(i.e. TST ;:::10 mm). One possible explanation of 
this could be that previous BCG increases the size 
of TST reaction but that this increase is limited to 
values of less than 10 mm. The corollary would be 
that TST reactions ;:::10 mm are influenced only by 
the history of contact, the country of origin or the 
age. Severa! more powerful studies demonstrate 
that the reactivity of young subjects, who received 
[1.08; 1.3 5) 
[0.50; 2.78) 
[2.23; 24] 
[0.91; 9.72] 
[1.00; 1.02) 
[0.17; 5.07] 
BCG vaccination at birth, is not significantly dif-
ferent from unvaccinated subjects [12, 14, 15, 21]. 
On the other hand, subjects vaccinated after the 
age of one year may present a persistently positive 
TST [7, 12, 22]. Wang's recentmeta-analysis sug-
gests that, in subjects without active TB, previous 
BCG immunization (in infancy) significantly in-
creases the likelihood of a TST ;:::10 mm for as long 
as 15 years and that the risk factors for infection 
and the clinical context modify the interpretation 
of the TST [23]. In our study, we assume that most 
children had been vaccinated at birth, according to 
the WHO recommendations [24], very likely 
strengthening the findings that BCG at birth does 
not influence TST reaction after the first year of 
life. However, in the logistic regression mode!, the 
CI 95% for the OR of the BCG vaccination was 
wide so that another explanation could be that our 
study has insufficient power. With more subjects, 
the proportion ofTST ;:::10 mm in vaccinated chil-
dren could well be significant. 
We found a significant interaction between 
BCG and history of contact. The mean increase of 
the TST size reaction due to history of contact 
is smaller in vaccinated children than in non vac-
cinated children. This suggests that BCG could 
have a limited protective effect against LTBI and 
haematogenous dissemination from the lungs. 
This observation has already been reported in sev-
eral animal studies such as the Fox study, which 
demonstrates the absence of haematogenous seed-
ing in BCG vaccinated guinea pigs (25]. This in-
teraction term is not significant in the logistic re-
gression mode! as it is less powerful than the lin-
ear regression. 
The children who received more than one 
BCG vaccination (i.e. the first BCG at birth, the 
second one at the age of 6-7 years) seem to pres-
ent a larger mean size of induration of the TST 
and a larger proportion ofTST ;:::10 mm than the 
children vaccinated only once, but they were too 
few in our study (9 children) to demonstrate a sig-
nificative difference. However, as confirmed by 
other larger studies, the effect of multiple BCG 
immunizations on the TST has to be kept in mind 
(26]. 
We showed that increasing age was a risk fac-
tor for TST ;:::10 mm, independently of known con-
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tact with a person suffering from TB. We also ob-
served a significant increase of the TST size with 
increasing age. This could be due to a longer pe-
riod of potential contactwith TB, as demonstrated 
in a Canadian study of a population of non BCG 
vaccinated school-children, health professional 
studeuts and young adult workers [2 7], even when 
the contact is unknown or undocumented. This 
may also be explained by cross-reaction with non 
tuberculous Mycobacteria, as postulated in an-
other Canadian study in which a double injection 
of PPD-T and PPD-B was used to demonstrate 
that some positive TST reactions were due to 
cross-reaction with environmental mycobacterial 
antigens [2 8]. We introduced an interaction term 
between BCG and age. It was neither significant 
in the linear nor in the logistic regression, suggest-
ing that the mean increase of the TST reaction size 
with age is the same in vaccinated and unvacci-
nated children. Indeed, the effect of BCG received 
at birth is known to wane rapidly with age, as 
demonstrated in the Lifschitz study, ranging from 
50% of skin tests ;;::10 mm at 6 months of age to 
0% after one year [6]. 
In our population of children up to 16 years of 
age, sex was not an independent risk factor. This 
seems to be different in the adult population where 
the prevalence ofTST ;;::10 mm and of TB varies 
according to sex. This difference in sex ratio be-
tween children and adults is well~demonstrated in 
other studies and is explained by the fact that boys 
and girls have similar social conditions [19], 
whereas this is not the case for adult men and 
women. Cases of tuberculosis among adultwomen 
might also have been under-reported in develop-
ing regions [29]. However, in our study, the wide 
confidence intervals, both in the linear and logis-
tic regression, imply that our study is not power-
ful enough to rule out this sex difference. 
This study suffers from several limitations. 
The first and most important limitation is that it 
lacks power to detect several risk factors for a 
greater TST reaction size or TST positivity. 
Secondly, we did not compare the results in 
this population of children composed of a major-
ity of migrant children with a control group of 
Swiss children, as there is currently no indication 
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